Global Devices for Inhaled Medications Market Research Report 2021

Publisher Name :
Date: 11-Jan-2021
No. of pages: 137
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Dry Powder Inhalers

- Metered-Dose Inhalers

- Nebulizers

- Soft Mist Inhaler

Segment by Application

- Clinic

- Hospital

- Home

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Consort Medical

- Inhalexper

- Cambridge Consultants

- Hovione

- Catalent, Inc

- VertMarkets, Inc

- Qualicaps

- 3M

- Aerovance

- AstraZeneca

- Boehringer Ingelheim

- Chiesi

- Cipla

- Civitas/Alkermes

- GlaxoSmithKline

- Hovione

- Mannkind

- Mantecorp

- Meda

- MicroDose Therapeutx

- Novartis

Global Devices for Inhaled Medications Market Research Report 2021

Table of Contents
1 Devices for Inhaled Medications Market Overview
1.1 Product Overview and Scope of Devices for Inhaled Medications
1.2 Devices for Inhaled Medications Segment by Type
1.2.1 Global Devices for Inhaled Medications Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dry Powder Inhalers
1.2.3 Metered-Dose Inhalers
1.2.4 Nebulizers
1.2.5 Soft Mist Inhaler
1.3 Devices for Inhaled Medications Segment by Application
1.3.1 Devices for Inhaled Medications Sales Comparison by Application: (2021-2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home
1.4 Global Devices for Inhaled Medications Market Size Estimates and Forecasts
1.4.1 Global Devices for Inhaled Medications Revenue 2016-2027
1.4.2 Global Devices for Inhaled Medications Sales 2016-2027
1.4.3 Devices for Inhaled Medications Market Size by Region: 2016 Versus 2021 Versus 2027
2 Devices for Inhaled Medications Market Competition by Manufacturers
2.1 Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2016-2021)
2.2 Global Devices for Inhaled Medications Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Devices for Inhaled Medications Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Devices for Inhaled Medications Manufacturing Sites, Area Served, Product Type
2.5 Devices for Inhaled Medications Market Competitive Situation and Trends
2.5.1 Devices for Inhaled Medications Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Devices for Inhaled Medications Players Market Share by Revenue
2.5.3 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Devices for Inhaled Medications Retrospective Market Scenario by Region
3.1 Global Devices for Inhaled Medications Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Devices for Inhaled Medications Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Devices for Inhaled Medications Market Facts & Figures by Country
3.3.1 North America Devices for Inhaled Medications Sales by Country
3.3.2 North America Devices for Inhaled Medications Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Devices for Inhaled Medications Market Facts & Figures by Country
3.4.1 Europe Devices for Inhaled Medications Sales by Country
3.4.2 Europe Devices for Inhaled Medications Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Devices for Inhaled Medications Market Facts & Figures by Region
3.5.1 Asia Pacific Devices for Inhaled Medications Sales by Region
3.5.2 Asia Pacific Devices for Inhaled Medications Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Devices for Inhaled Medications Market Facts & Figures by Country
3.6.1 Latin America Devices for Inhaled Medications Sales by Country
3.6.2 Latin America Devices for Inhaled Medications Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Devices for Inhaled Medications Market Facts & Figures by Country
3.7.1 Middle East and Africa Devices for Inhaled Medications Sales by Country
3.7.2 Middle East and Africa Devices for Inhaled Medications Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Devices for Inhaled Medications Historic Market Analysis by Type
4.1 Global Devices for Inhaled Medications Sales Market Share by Type (2016-2021)
4.2 Global Devices for Inhaled Medications Revenue Market Share by Type (2016-2021)
4.3 Global Devices for Inhaled Medications Price by Type (2016-2021)
5 Global Devices for Inhaled Medications Historic Market Analysis by Application
5.1 Global Devices for Inhaled Medications Sales Market Share by Application (2016-2021)
5.2 Global Devices for Inhaled Medications Revenue Market Share by Application (2016-2021)
5.3 Global Devices for Inhaled Medications Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Consort Medical
6.1.1 Consort Medical Corporation Information
6.1.2 Consort Medical Description and Business Overview
6.1.3 Consort Medical Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Consort Medical Product Portfolio
6.1.5 Consort Medical Recent Developments/Updates
6.2 Inhalexper
6.2.1 Inhalexper Corporation Information
6.2.2 Inhalexper Description and Business Overview
6.2.3 Inhalexper Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Inhalexper Product Portfolio
6.2.5 Inhalexper Recent Developments/Updates
6.3 Cambridge Consultants
6.3.1 Cambridge Consultants Corporation Information
6.3.2 Cambridge Consultants Description and Business Overview
6.3.3 Cambridge Consultants Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cambridge Consultants Product Portfolio
6.3.5 Cambridge Consultants Recent Developments/Updates
6.4 Hovione
6.4.1 Hovione Corporation Information
6.4.2 Hovione Description and Business Overview
6.4.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hovione Product Portfolio
6.4.5 Hovione Recent Developments/Updates
6.5 Catalent, Inc
6.5.1 Catalent, Inc Corporation Information
6.5.2 Catalent, Inc Description and Business Overview
6.5.3 Catalent, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Catalent, Inc Product Portfolio
6.5.5 Catalent, Inc Recent Developments/Updates
6.6 VertMarkets, Inc
6.6.1 VertMarkets, Inc Corporation Information
6.6.2 VertMarkets, Inc Description and Business Overview
6.6.3 VertMarkets, Inc Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.6.4 VertMarkets, Inc Product Portfolio
6.6.5 VertMarkets, Inc Recent Developments/Updates
6.7 Qualicaps
6.6.1 Qualicaps Corporation Information
6.6.2 Qualicaps Description and Business Overview
6.6.3 Qualicaps Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Qualicaps Product Portfolio
6.7.5 Qualicaps Recent Developments/Updates
6.8 3M
6.8.1 3M Corporation Information
6.8.2 3M Description and Business Overview
6.8.3 3M Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.8.4 3M Product Portfolio
6.8.5 3M Recent Developments/Updates
6.9 Aerovance
6.9.1 Aerovance Corporation Information
6.9.2 Aerovance Description and Business Overview
6.9.3 Aerovance Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Aerovance Product Portfolio
6.9.5 Aerovance Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.10.4 AstraZeneca Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim Devices for Inhaled Medications Description and Business Overview
6.11.3 Boehringer Ingelheim Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Boehringer Ingelheim Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Chiesi
6.12.1 Chiesi Corporation Information
6.12.2 Chiesi Devices for Inhaled Medications Description and Business Overview
6.12.3 Chiesi Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Chiesi Product Portfolio
6.12.5 Chiesi Recent Developments/Updates
6.13 Cipla
6.13.1 Cipla Corporation Information
6.13.2 Cipla Devices for Inhaled Medications Description and Business Overview
6.13.3 Cipla Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Cipla Product Portfolio
6.13.5 Cipla Recent Developments/Updates
6.14 Civitas/Alkermes
6.14.1 Civitas/Alkermes Corporation Information
6.14.2 Civitas/Alkermes Devices for Inhaled Medications Description and Business Overview
6.14.3 Civitas/Alkermes Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Civitas/Alkermes Product Portfolio
6.14.5 Civitas/Alkermes Recent Developments/Updates
6.15 GlaxoSmithKline
6.15.1 GlaxoSmithKline Corporation Information
6.15.2 GlaxoSmithKline Devices for Inhaled Medications Description and Business Overview
6.15.3 GlaxoSmithKline Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.15.4 GlaxoSmithKline Product Portfolio
6.15.5 GlaxoSmithKline Recent Developments/Updates
6.16 Hovione
6.16.1 Hovione Corporation Information
6.16.2 Hovione Devices for Inhaled Medications Description and Business Overview
6.16.3 Hovione Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Hovione Product Portfolio
6.16.5 Hovione Recent Developments/Updates
6.17 Mannkind
6.17.1 Mannkind Corporation Information
6.17.2 Mannkind Devices for Inhaled Medications Description and Business Overview
6.17.3 Mannkind Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Mannkind Product Portfolio
6.17.5 Mannkind Recent Developments/Updates
6.18 Mantecorp
6.18.1 Mantecorp Corporation Information
6.18.2 Mantecorp Devices for Inhaled Medications Description and Business Overview
6.18.3 Mantecorp Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Mantecorp Product Portfolio
6.18.5 Mantecorp Recent Developments/Updates
6.19 Meda
6.19.1 Meda Corporation Information
6.19.2 Meda Devices for Inhaled Medications Description and Business Overview
6.19.3 Meda Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Meda Product Portfolio
6.19.5 Meda Recent Developments/Updates
6.20 MicroDose Therapeutx
6.20.1 MicroDose Therapeutx Corporation Information
6.20.2 MicroDose Therapeutx Devices for Inhaled Medications Description and Business Overview
6.20.3 MicroDose Therapeutx Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.20.4 MicroDose Therapeutx Product Portfolio
6.20.5 MicroDose Therapeutx Recent Developments/Updates
6.21 Novartis
6.21.1 Novartis Corporation Information
6.21.2 Novartis Devices for Inhaled Medications Description and Business Overview
6.21.3 Novartis Devices for Inhaled Medications Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Novartis Product Portfolio
6.21.5 Novartis Recent Developments/Updates
7 Devices for Inhaled Medications Manufacturing Cost Analysis
7.1 Devices for Inhaled Medications Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Devices for Inhaled Medications
7.4 Devices for Inhaled Medications Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Devices for Inhaled Medications Distributors List
8.3 Devices for Inhaled Medications Customers
9 Devices for Inhaled Medications Market Dynamics
9.1 Devices for Inhaled Medications Industry Trends
9.2 Devices for Inhaled Medications Growth Drivers
9.3 Devices for Inhaled Medications Market Challenges
9.4 Devices for Inhaled Medications Market Restraints
10 Global Market Forecast
10.1 Devices for Inhaled Medications Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Devices for Inhaled Medications by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Devices for Inhaled Medications by Type (2022-2027)
10.2 Devices for Inhaled Medications Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Devices for Inhaled Medications by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Devices for Inhaled Medications by Application (2022-2027)
10.3 Devices for Inhaled Medications Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Devices for Inhaled Medications by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Devices for Inhaled Medications by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Devices for Inhaled Medications Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Devices for Inhaled Medications Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Devices for Inhaled Medications Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Devices for Inhaled Medications Covered in This Study
Table 5. Global Devices for Inhaled Medications Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Devices for Inhaled Medications Sales Share by Manufacturers (2016-2021)
Table 7. Global Devices for Inhaled Medications Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Devices for Inhaled Medications Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Devices for Inhaled Medications Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Devices for Inhaled Medications Manufacturing Sites and Area Served
Table 11. Manufacturers Devices for Inhaled Medications Product Type
Table 12. Global Devices for Inhaled Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Devices for Inhaled Medications as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Devices for Inhaled Medications Sales by Region (2016-2021) & (K Units)
Table 16. Global Devices for Inhaled Medications Sales Market Share by Region (2016-2021)
Table 17. Global Devices for Inhaled Medications Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Devices for Inhaled Medications Sales by Country (2016-2021) & (K Units)
Table 19. North America Devices for Inhaled Medications Sales Market Share by Country (2016-2021)
Table 20. North America Devices for Inhaled Medications Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Devices for Inhaled Medications Revenue Market Share by Country (2016-2021)
Table 22. Europe Devices for Inhaled Medications Sales by Country (2016-2021) & (K Units)
Table 23. Europe Devices for Inhaled Medications Sales Market Share by Country (2016-2021)
Table 24. Europe Devices for Inhaled Medications Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Devices for Inhaled Medications Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Devices for Inhaled Medications Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Devices for Inhaled Medications Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Devices for Inhaled Medications Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Devices for Inhaled Medications Revenue Market Share by Region (2016-2021)
Table 30. Latin America Devices for Inhaled Medications Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Devices for Inhaled Medications Sales Market Share by Country (2016-2021)
Table 32. Latin America Devices for Inhaled Medications Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Devices for Inhaled Medications Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Devices for Inhaled Medications Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Devices for Inhaled Medications Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Devices for Inhaled Medications Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Devices for Inhaled Medications Revenue Market Share by Country (2016-2021)
Table 38. Global Devices for Inhaled Medications Sales (K Units) by Type (2016-2021)
Table 39. Global Devices for Inhaled Medications Sales Market Share by Type (2016-2021)
Table 40. Global Devices for Inhaled Medications Revenue (Million US$) by Type (2016-2021)
Table 41. Global Devices for Inhaled Medications Revenue Share by Type (2016-2021)
Table 42. Global Devices for Inhaled Medications Price (USD/Unit) by Type (2016-2021)
Table 43. Global Devices for Inhaled Medications Sales (K Units) by Application (2016-2021)
Table 44. Global Devices for Inhaled Medications Sales Market Share by Application (2016-2021)
Table 45. Global Devices for Inhaled Medications Revenue (Million US$) by Application (2016-2021)
Table 46. Global Devices for Inhaled Medications Revenue Share by Application (2016-2021)
Table 47. Global Devices for Inhaled Medications Price (USD/Unit) by Application (2016-2021)
Table 48. Consort Medical Corporation Information
Table 49. Consort Medical Description and Business Overview
Table 50. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Consort Medical Devices for Inhaled Medications Product
Table 52. Consort Medical Recent Developments/Updates
Table 53. Inhalexper Corporation Information
Table 54. Inhalexper Description and Business Overview
Table 55. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Inhalexper Devices for Inhaled Medications Product
Table 57. Inhalexper Recent Developments/Updates
Table 58. Cambridge Consultants Corporation Information
Table 59. Cambridge Consultants Description and Business Overview
Table 60. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Cambridge Consultants Devices for Inhaled Medications Product
Table 62. Cambridge Consultants Recent Developments/Updates
Table 63. Hovione Corporation Information
Table 64. Hovione Description and Business Overview
Table 65. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Hovione Devices for Inhaled Medications Product
Table 67. Hovione Recent Developments/Updates
Table 68. Catalent, Inc Corporation Information
Table 69. Catalent, Inc Description and Business Overview
Table 70. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Catalent, Inc Devices for Inhaled Medications Product
Table 72. Catalent, Inc Recent Developments/Updates
Table 73. VertMarkets, Inc Corporation Information
Table 74. VertMarkets, Inc Description and Business Overview
Table 75. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. VertMarkets, Inc Devices for Inhaled Medications Product
Table 77. VertMarkets, Inc Recent Developments/Updates
Table 78. Qualicaps Corporation Information
Table 79. Qualicaps Description and Business Overview
Table 80. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Qualicaps Devices for Inhaled Medications Product
Table 82. Qualicaps Recent Developments/Updates
Table 83. 3M Corporation Information
Table 84. 3M Description and Business Overview
Table 85. 3M Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. 3M Devices for Inhaled Medications Product
Table 87. 3M Recent Developments/Updates
Table 88. Aerovance Corporation Information
Table 89. Aerovance Description and Business Overview
Table 90. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Aerovance Devices for Inhaled Medications Product
Table 92. Aerovance Recent Developments/Updates
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Business Overview
Table 95. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. AstraZeneca Devices for Inhaled Medications Product
Table 97. AstraZeneca Recent Developments/Updates
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Business Overview
Table 100. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Boehringer Ingelheim Devices for Inhaled Medications Product
Table 102. Boehringer Ingelheim Recent Developments/Updates
Table 103. Chiesi Corporation Information
Table 104. Chiesi Description and Business Overview
Table 105. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Chiesi Devices for Inhaled Medications Product
Table 107. Chiesi Recent Developments/Updates
Table 108. Cipla Corporation Information
Table 109. Cipla Description and Business Overview
Table 110. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Cipla Devices for Inhaled Medications Product
Table 112. Cipla Recent Developments/Updates
Table 113. Civitas/Alkermes Corporation Information
Table 114. Civitas/Alkermes Description and Business Overview
Table 115. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Civitas/Alkermes Devices for Inhaled Medications Product
Table 117. Civitas/Alkermes Recent Developments/Updates
Table 118. GlaxoSmithKline Corporation Information
Table 119. GlaxoSmithKline Description and Business Overview
Table 120. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. GlaxoSmithKline Devices for Inhaled Medications Product
Table 122. GlaxoSmithKline Recent Developments/Updates
Table 123. Hovione Corporation Information
Table 124. Hovione Description and Business Overview
Table 125. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Hovione Devices for Inhaled Medications Product
Table 127. Hovione Recent Developments/Updates
Table 128. Mannkind Corporation Information
Table 129. Mannkind Description and Business Overview
Table 130. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Mannkind Devices for Inhaled Medications Product
Table 132. Mannkind Recent Developments/Updates
Table 133. Mantecorp Corporation Information
Table 134. Mantecorp Description and Business Overview
Table 135. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Mantecorp Devices for Inhaled Medications Product
Table 137. Mantecorp Recent Developments/Updates
Table 138. Meda Corporation Information
Table 139. Meda Description and Business Overview
Table 140. Meda Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Meda Devices for Inhaled Medications Product
Table 142. Meda Recent Developments/Updates
Table 143. MicroDose Therapeutx Corporation Information
Table 144. MicroDose Therapeutx Description and Business Overview
Table 145. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. MicroDose Therapeutx Devices for Inhaled Medications Product
Table 147. MicroDose Therapeutx Recent Developments/Updates
Table 148. Novartis Corporation Information
Table 149. Novartis Description and Business Overview
Table 150. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Novartis Devices for Inhaled Medications Product
Table 152. Novartis Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Devices for Inhaled Medications Distributors List
Table 156. Devices for Inhaled Medications Customers List
Table 157. Devices for Inhaled Medications Market Trends
Table 158. Devices for Inhaled Medications Growth Drivers
Table 159. Devices for Inhaled Medications Market Restraints
Table 160. Global Devices for Inhaled Medications Sales Forecast by Type (2022-2027) & (K Units)
Table 161. Global Devices for Inhaled Medications Sales Market Share Forecast by Type (2022-2027)
Table 162. Global Devices for Inhaled Medications Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 163. Global Devices for Inhaled Medications Revenue Market Share Forecast by Type (2022-2027)
Table 164. Global Devices for Inhaled Medications Sales Forecast by Application (2022-2027) & (K Units)
Table 165. Global Devices for Inhaled Medications Sales Market Share Forecast by Application (2022-2027)
Table 166. Global Devices for Inhaled Medications Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 167. Global Devices for Inhaled Medications Revenue Market Share Forecast by Application (2022-2027)
Table 168. Global Devices for Inhaled Medications Sales Forecast by Region (2022-2027) & (K Units)
Table 169. Global Devices for Inhaled Medications Sales Market Share Forecast by Region (2022-2027)
Table 170. Global Devices for Inhaled Medications Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 171. Global Devices for Inhaled Medications Revenue Market Share Forecast by Region (2022-2027)
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Devices for Inhaled Medications
Figure 2. Global Devices for Inhaled Medications Market Share by Type in 2020 & 2027
Figure 3. Dry Powder Inhalers Product Picture
Figure 4. Metered-Dose Inhalers Product Picture
Figure 5. Nebulizers Product Picture
Figure 6. Soft Mist Inhaler Product Picture
Figure 7. Global Devices for Inhaled Medications Market Share by Application in 2020 & 2027
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Home
Figure 11. Global Devices for Inhaled Medications Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Devices for Inhaled Medications Market Size 2016-2027 (US$ Million)
Figure 13. Global Devices for Inhaled Medications Sales 2016-2027 (K Units)
Figure 14. Global Devices for Inhaled Medications Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Devices for Inhaled Medications Sales Share by Manufacturers in 2020
Figure 16. Global Devices for Inhaled Medications Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Devices for Inhaled Medications Players: Market Share by Revenue in 2020
Figure 18. Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Devices for Inhaled Medications Sales Market Share by Region (2016-2021)
Figure 20. Global Devices for Inhaled Medications Sales Market Share by Region in 2020
Figure 21. Global Devices for Inhaled Medications Revenue Market Share by Region (2016-2021)
Figure 22. Global Devices for Inhaled Medications Revenue Market Share by Region in 2020
Figure 23. U.S. Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Devices for Inhaled Medications Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Devices for Inhaled Medications by Type (2016-2021)
Figure 48. Sales Market Share of Devices for Inhaled Medications by Application (2016-2021)
Figure 49. Sales Market Share of Devices for Inhaled Medications by Application in 2020
Figure 50. Revenue Share of Devices for Inhaled Medications by Application (2016-2021)
Figure 51. Revenue Share of Devices for Inhaled Medications by Application in 2020
Figure 52. Manufacturing Cost Structure of Devices for Inhaled Medications
Figure 53. Manufacturing Process Analysis of Devices for Inhaled Medications
Figure 54. Devices for Inhaled Medications Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Bowel Management System Market Forecast 2021-2028
    Published: 25-Jan-2021        Price: US 2500 Onwards        Pages: 217
    KEY FINDINGS The global bowel management system market is set to project a CAGR of 3.12% during the forecast period, 2021-2028. The increasing aging population, the growing incidence of gastrointestinal disorders, and the rising prevalence of irritable bowel syndrome, are driving the market growth. MARKET INSIGHTS A bowel management system is used for fecal incontinence, aiding them in keeping the skin free from contaminants and moisture. It minimizes infection trans......
  • North America Bowel Management System Market Forecast 2021-2028
    Published: 25-Jan-2021        Price: US 1250 Onwards        Pages: 134
    KEY FINDINGS The North America bowel management system market is registered to project a CAGR of 2.47%, during the forecast period of 2021 to 2028. The surging geriatric population and consistent research and development towards innovative bowel management system devices for fecal management, are expected to reinforce the region's market growth. MARKET INSIGHTS The North America bowel management system market growth is analyzed by assessing Canada and the United Stat......
  • Europe Bowel Management System Market Forecast 2021-2028
    Published: 25-Jan-2021        Price: US 1250 Onwards        Pages: 143
    KEY FINDINGS The Europe bowel management system market is expected to record a CAGR of 3.35%, over the forecast period of 2021 to 2028. The region's market growth is mainly facilitated by the surging awareness among patients about the availability of bowel management system devices, the well-established healthcare infrastructure, growing governmental support, and the increased healthcare expenditure. MARKET INSIGHTS The Europe bowel management system market growth is......
  • Asia Pacific Bowel Management System Market Forecast 2021-2028
    Published: 25-Jan-2021        Price: US 1250 Onwards        Pages: 148
    KEY FINDINGS The Asia Pacific bowel management system market is predicted to project a CAGR of 3.93% during the forecast period, 2021-2028. The increasing healthcare reforms, technological advancements, and product launches by leading manufacturers, are facilitating the market growth. MARKET INSIGHTS Vietnam, India, Japan, Australia & New Zealand, China, South Korea, Indonesia, Thailand, and Rest of Asia Pacific, are assessed for the Asia Pacific bowel management sys......
  • Global Centralized Patient Monitoring System Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 130
    According to this latest study, the 2020 growth of Centralized Patient Monitoring System will have significant change from previous year. By the most conservative estimates of global Centralized Patient Monitoring System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 490.5 million in 2019. Over the next five years the Centralized Patient Monitoring System market will register a 6.3% CAGR in terms of revenue, the global market size will rea......
  • Global Livestock Animal Vaccines Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 159
    According to this latest study, the 2020 growth of Livestock Animal Vaccines will have significant change from previous year. By the most conservative estimates of global Livestock Animal Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4632.4 million in 2019. Over the next five years the Livestock Animal Vaccines market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 5868.7 million by 2025.......
  • Global Clinical Reference Laboratory Services Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Clinical Reference Laboratory Services will have significant change from previous year. By the most conservative estimates of global Clinical Reference Laboratory Services market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 11450 million in 2019. Over the next five years the Clinical Reference Laboratory Services market will register a 5.4% CAGR in terms of revenue, the global market size will ......
  • Global Steam Chemical Indicator Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 139
    According to this latest study, the 2020 growth of Steam Chemical Indicator will have significant change from previous year. By the most conservative estimates of global Steam Chemical Indicator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 105.9 million in 2019. Over the next five years the Steam Chemical Indicator market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 137.2 million by 2025. ......
  • Global Oral Guided Bone Regeneration (GTR) Membrane Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Oral Guided Bone Regeneration (GTR) Membrane will have significant change from previous year. By the most conservative estimates of global Oral Guided Bone Regeneration (GTR) Membrane market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 201.6 million in 2019. Over the next five years the Oral Guided Bone Regeneration (GTR) Membrane market will register a 6.6% CAGR in terms of revenue, the global......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs